Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/1/02 → 04/30/04 |
Funding
- Pfizer Incorporated: $3,150.00
A Phase 3B Multi-Center Double-Blind Randomized Placebo-Controlled Parallel Group Study of Darifenacin in Subjects with Overactive Bladder
- Baker, David (PI)
- Budnick, Lauri (CoPI)
Project: Research